GoldBamboo.com - Knowledge is strong medicine
  

Joint Determinants of Bone Density and CVD Calcification - Article


  Not Signed In - Sign In / Register






All Health Topics by letter:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

 

Clinical Trial: Joint Determinants of Bone Density and CVD Calcification

This study is no longer recruiting patients.

Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)

Purpose

To evaluate the relationship bone marrow density and coronary artery and aortic calcification.

Condition
Atherosclerosis
Cardiovascular Diseases
Heart Diseases
Osteoporosis

MedlinePlus related topics:  Heart Diseases;   Heart Diseases--Prevention;   Osteoporosis;   Vascular Diseases

Study Type: Observational
Study Design: Natural History, Defined Population

Further Study Details: 

Study start: September 2001;  Study completion: July 2005

BACKGROUND: There is growing evidence of a link between osteoporosis and atherosclerosis. Recent studies document that bone mineral density (BMD) is inversely correlated with severity of aortic and coronary artery calcification, markers of atherosclerosis. Cardiovascular disease and osteoporosis have tremendous negative public health impacts on the nation. Besides increased mortality, these negative impacts include severely diminished quality of life and huge financial burdens. With an ever aging population, this situation will get even worse. As increasing numbers of individuals now live well into their 80s and 90s, there is a great deal of interest on what has become known as healthy aging.

The study is in response to a Request for Applications (RFA) entitled Bone Formation and Calcification in Cardiovascular Disease which was developed jointly with the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to support research into the pathophysiology and molecular mechanisms of vascular calcification, and the possible links between vascular calcification, bone formation, and cardiovascular disease. The RFA was released in January, 2001.

DESIGN NARRATIVE: The study evaluates the relationship between BMD and coronary artery and aortic calcification, measured by electron beam computed tomography, in 700 members of a large Amish pedigree already participating in the Amish Family Osteoporosis Study (AFOS). By focusing on families, the investigators hope to tease out the respective contributions of genetic and non-genetic factors to this clustering of traits. The AFOS was initiated in 1997 to identify genes influencing susceptibility to osteoporosis in families ascertained for fracture risk. Through NIH funding available to the AFOS parent study, the investigators willl genotype 391 highly polymorphic short tandem repeat (STR) markers spaced at approximately 10 cM intervals and perform a genome-wide scan to detect quantitative trait loci (QTLs) associated with variation in bone marrow density and related traits. The Old Order Amish are ideal for the studies since they are a closed founder population who are relatively genetically homogeneous, have very large family sizes, and well-documented genealogies. The study uses the available measures of bone marrow density, related traits, and genotypes in the AFOS along with the newly collected measures of vascular calcification.

The specific goals are to determine if bone marrow density is correlated with coronary artery and aortic calcification (CAC) and, if so, to determine the contribution of common genes or shared environments to this association in families. The investigators will next assess genetic heritability and non-genetic contributions to variability in vascular calcification determinants of CAC in these families. They will assess the individual and joint contributions of lipid oxidation to bone marrow density and vascular calcification. Using the extensive genotyping that will be available, they will perform a genome wide scan of coronary artery and aortic calcification. These results will complement the similar analyses obtained on the bone-related phenotypes. Finally, they will determine if chromosomal regions linked to variation in bone marrow density are also linked to variation in vascular calcification or to another possible joint determinant such as CAC (or to lipid oxidation).

Eligibility

Genders Eligible for Study:  Both

Criteria

No eligibility criteria

Location Information

Study chairs or principal investigators

Braxton Mitchell,  University of Maryland Baltimore Professional School   

More Information

Publications

Kammerer CM, Dualan AA, Samollow PB, Perisse AR, Bauer RL, MacCluer JW, O'Leary DH, Mitchell BD. Bone mineral density, carotid artery intimal medial thickness, and the vitamin D receptor BsmI polymorphism in Mexican American women. Calcif Tissue Int. 2004 Oct;75(4):292-8. Epub 2004 Jul 30.

Brown LB, Streeten EA, Shuldiner AR, Almasy LA, Peyser PA, Mitchell BD. Assessment of sex-specific genetic and environmental effects on bone mineral density. Genet Epidemiol. 2004 Sep;27(2):153-61.

Study ID Numbers:  1169
Record last reviewed:  February 2005
Last Updated:  February 3, 2005
Record first received:  May 16, 2002
ClinicalTrials.gov Identifier:  NCT00037414
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource

October 12, 2008



Page Updated: June 12, 2007
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.